CD13 Antibody [WM15] (PE)

Product Specifications

Background

The WM-15 monoclonal antibody specifically reacts with human CD13, 150-170 type II transmembrane ectoenzyme also named aminopeptidase N and gp150. It is expressed by granulocytes and monocytes, epithelial cells, and endothelial cells. CD13 plays a role in the terminal degradation of peptides, antigen processing, and chemokine cleavage, and cellular adhesion.

NCBI Gene ID

290

Swiss Prot

P15144

Host

Mouse

Reactivity

Human

Clonality

Monoclonal

Clone

WM15

Conjugation

Type

Primary Antibodies

Field of Research

Innate Immunity

Purification

The monoclonal antibody was purified utilizing affinity chromatography and unreacted dye was removed from the product.

Concentration

Batch dependent

Buffer

Phosphate-buffered aqueous solution, ≤0.09% Sodium azide, may contain carrier protein/stabilizer, ph7.2.

Modification

None

Shipping Conditions

Blue Ice

Storage Conditions

The product should be stored undiluted at 4˚ C and should be protected from prolonged exposure to light. Do not freeze.

Fragment

Mouse IgG1, kappa

Specificity

The WM-15 monoclonal antibody specifically reacts with human CD13, 150-170 type II transmembrane ectoenzyme also named aminopeptidase N and gp150.

Symbol

ANPEP

NCBI Official Name

Alanyl (membrane) aminopeptidase

NCBI Organism

Homo sapiens

Background Reference 01

Barclay, A. N., Brown, M. H., Law, S. A. K. A., McKnight, A. J., Tomlinson, M. G., van der Merwe, P. A. (1997) .The leucocyte antigen factsbook. Academic Press.

Background Reference 02

Look, A. T., Ashmun, R. A., Shapiro, L. H., Peiper, S. C. (1989) . Human myeloid plasma membrane glycoprotein CD13 (gp150) is identical to aminopeptidase N.Journal of Clinical Investigation,83 (4), 1299.

Background Reference 03

Favaloro, E. J., Moraitis, N., Bradstock, K., Koutts, J. (1990) . Co‐expression of haemopoietic antigens on vascular endothelial cells: a detailed phenotypic analysis.British journal of haematology,74 (4), 385-394.